India, May 11 -- Global investment firm The Carlyle Group and the existing promoters of SeQuent Scientific Limited today announced that CA Harbor Investments, an affiliated entity of CAP V Mauritius Limited and The Carlyle Group (together, "Carlyle"), has agreed to acquirean equity stake ofup to 74% in SeQuent Scientific Limited ("SeQuent"), the largest pure-play animal healthcare company in India.

CA Harbor Investmentsproposes to acquirea majority stake inSeQuentvia private share purchase agreements, for a purchase price of INR 86 per share. Pursuant to the Securities and Exchange Board of India (SEBI)'s Takeover Regulations, the proposed transaction will trigger a mandatory open offer byCA Harbor Investmentsand CAP V Mauritius Limited ...